Maravai LifeSciences
MRVI
$7.30
Share price
-4.07%
Change (1 day)
-48.56%
Change (1 year)
Categories
Operating Margin for Maravai LifeSciences (MRVI)
Operating Margin as of April 2024 (TTM): 35.25%
According to Maravai LifeSciences 's latest financial reports and stock price the company's current Operating Margin is 35.25%. At the end of 2022 the company had an Operating Margin of 62.45%.
Operating Margin history for Maravai LifeSciences from 2020 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 62.45% | -5.95% |
| 2021 | 66.41% | 130.94% |
| 2020 | 28.76% | -803.26% |
| 2019 | -4.09% | -69.31% |
| 2018 | -13.32% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -591.52% | -1,778.07% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -129.00% | -465.96% | 🇬🇧 UK |
 Novavax NVAX | -149.57% | -524.31% | 🇺🇸 USA |
 Novocure
NVCR | -37.52% | -206.44% | Jersey |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.